These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3313283)

  • 1. A promoter probe vector (pJAC4) that utilizes the ampC beta-lactamase gene of Escherichia coli.
    Jaurin B
    Nucleic Acids Res; 1987 Oct; 15(20):8567. PubMed ID: 3313283
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-locus sequence typing of Escherichia coli isolates with acquired ampC genes and ampC promoter mutations.
    Lewis JA; Moore PC; Arnold DL; Lawrance LM
    Diagn Microbiol Infect Dis; 2016 Nov; 86(3):265-267. PubMed ID: 27595455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.
    Jaurin B; Grundström T
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4897-901. PubMed ID: 6795623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel ampC beta-lactamase promoter in a clinical isolate of Escherichia coli.
    Olsson O; Bergström S; Normark S
    EMBO J; 1982; 1(11):1411-6. PubMed ID: 6765197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in AmpC β-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016).
    den Drijver E; Verweij JJ; Verhulst C; Oome S; Soer J; Willemsen I; Schrauwen EJA; Kluytmans-van den Bergh MFQ; Kluytmans JAJW
    PLoS One; 2018; 13(10):e0204864. PubMed ID: 30273375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ampC beta-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella.
    Olsson O; Bergström S; Lindberg FP; Normark S
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7556-60. PubMed ID: 6369321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of promoter-active DNA sequences from Chainia (NCL 82.5.1) in Escherichia coli.
    Chauthaiwale VM; Deshpande VV
    Biofactors; 1994 May; 4(3-4):173-5. PubMed ID: 7916963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
    Wang Y; Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two RT-PCR methods for quantifying ampC specific transcripts in Escherichia coli strains.
    Corvec S; Caroff N; Espaze E; Marraillac J; Drugeon H; Reynaud A
    FEMS Microbiol Lett; 2003 Nov; 228(2):187-91. PubMed ID: 14638423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli.
    Pascual V; Ortiz G; Simó M; Alonso N; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    J Antimicrob Chemother; 2015 Mar; 70(3):899-904. PubMed ID: 25468902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of acquired AmpC β-lactamase genes in Sydney, Australia.
    Tagg KA; Ginn AN; Jiang X; Ellem J; Partridge SR; Iredell JR
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):56-8. PubMed ID: 26099646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementation of growth defect in an ampC deletion mutant of Escherichia coli.
    Bishop RE; Weiner JH
    FEMS Microbiol Lett; 1993 Dec; 114(3):349-54. PubMed ID: 8288112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of a chromosomal class C beta-lactamase and its regulatory gene in Laribacter hongkongensis.
    Lau SK; Ho PL; Li MW; Tsoi HW; Yung RW; Woo PC; Yuen KY
    Antimicrob Agents Chemother; 2005 May; 49(5):1957-64. PubMed ID: 15855519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory components in Citrobacter freundii ampC beta-lactamase induction.
    Lindberg F; Westman L; Normark S
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4620-4. PubMed ID: 2991883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.
    Caroff N; Espaze E; Bérard I; Richet H; Reynaud A
    FEMS Microbiol Lett; 1999 Apr; 173(2):459-65. PubMed ID: 10227175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.
    Alonso N; Miró E; Pascual V; Rivera A; Simó M; Garcia MC; Xercavins M; Morera MA; Espejo E; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E; Navarro F; Mirelis B; Coll P
    Int J Antimicrob Agents; 2016 Jan; 47(1):62-8. PubMed ID: 26607336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.